EMA Authorised: Humalog (insulin lispro) — Eli Lilly Nederland B.V.

View source ↗

Summary

Humalog (insulin lispro) by Eli Lilly Nederland B.V. has been authorised for use in the European Union for diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Humalog (insulin lispro)

Snippet

Status: Authorised. Therapeutic area: Diabetes Mellitus. MAH: Eli Lilly Nederland B.V.. Decision date: 09/07/2026